Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2024 Q3
6 of 19 quarters
Total Value
$76.07M
Total Shares
4.12M
Net Share Change
+190.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$76.07M
4.12M
1.5%
ADD
+190.4K
(+4.8%)
Maverick Capital
$76.07M
4.12M shares
ADD
+190.4K
(+4.8%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy